Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Ovarian Cancer
Conditions: Ovarian Cancer; Low Grade Serous Carcinoma; Primary Peritoneal Carcinoma; Fallopian Tube Cancer Intervention: Drug: Pembrolizumab Sponsors: North Eastern German Society of Gynaecological Oncology; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Germany Health | OBGYN | Ovarian Cancer | Ovaries | Research | Study